{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:48:49Z","timestamp":1764251329804},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T00:00:00Z","timestamp":1385337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0081579","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:59:16Z","timestamp":1385427556000},"page":"e81579","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Insulin\/IGF-I Signaling Pathways Enhances Tumor Cell Invasion through Bisecting GlcNAc N-glycans Modulation. An Interplay with E-Cadherin"],"prefix":"10.1371","volume":"8","author":[{"given":"Julio Cesar Madureira","family":"de-Freitas-Junior","sequence":"first","affiliation":[]},{"given":"Sandra","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Ana M.","family":"Dias","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Cabral","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Seruca","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Andr\u00e9s","family":"Morgado-D\u00edaz","sequence":"additional","affiliation":[]},{"given":"Celso A.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Salom\u00e9 S.","family":"Pinho","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,11,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10911-008-9099-z","article-title":"IGF and insulin receptor signaling in breast cancer","volume":"13","author":"A Belfiore","year":"2008","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"M Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1158\/1535-7163.MCT-07-0070","article-title":"A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo","volume":"6","author":"QS Ji","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1535-7163.MCT-06-0080","article-title":"Disrupting insulin-like growth factor signaling as a potential cancer therapy","volume":"6","author":"D Sachdev","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref5","first-page":"178","article-title":"Monoclonal antibodies against components of the IGF system for cancer treatment","volume":"2","author":"Y Feng","year":"2008","journal-title":"Curr Opin Drug Discov Devel"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/1535-7163.MCT-05-0048","article-title":"Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody","volume":"4","author":"Y Wang","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1158\/1078-0432.CCR-10-2274","article-title":"18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R\/IR inhibitor, in preclinical mouse models of lung cancer","volume":"17","author":"ET McKinley","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1478-811X-9-10","article-title":"IGF-1 increases invasive potential of MCF 7 breast cancer cells and induces activation of latent TGF-\u03b21 resulting in epithelial to mesenchymal transition","volume":"9","author":"LA Walsh","year":"2011","journal-title":"Cell Commun Signal"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/01635581.2012.630161","article-title":"Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of \u03b2-catenin signaling in hormone refractory PC-3 prostate cancer cells","volume":"64","author":"J Lee","year":"2012","journal-title":"Nutr Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial mesenchymal transitions","volume":"7","author":"JP Thiery","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1053\/j.gastro.2009.02.065","article-title":"Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression","volume":"136","author":"C Oliveira","year":"2009","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1200\/JCO.2012.44.4612","article-title":"Somatic mutations and deletions of the E-cadherin gene predict poor survival of gastric cancer patients","volume":"31","author":"G Corso","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.4032","article-title":"Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 upregulation in intestinal gastric cancer","volume":"228","author":"J Carvalho","year":"2012","journal-title":"J Pathol"},{"key":"ref14","first-page":"297","article-title":"Epithelial E- and P-cadherins: Role and clinical significance in cancer","volume":"1826","author":"J Paredes","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00018-010-0595-0","article-title":"Modulation of E-cadherin function and dysfunction by N-glycosylation","volume":"68","author":"SS Pinho","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00280-010-1477-8","article-title":"Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell-cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells","volume":"68","author":"JC de Freitas Junior","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.bbagen.2012.10.021","article-title":"E-cadherin and adherens-junctions stability in gastric carcinoma: Functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V","volume":"1830","author":"SS Pinho","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbrc.2009.01.024","article-title":"Role of E-cadherin N-glycosylation profile in a mammary tumor model","volume":"379","author":"SS Pinho","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/hmg\/ddp194","article-title":"The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin","volume":"18","author":"SS Pinho","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"13038","DOI":"10.1074\/jbc.M601961200","article-title":"Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase III and the bisected N-glycans in GE11 epithelial cells. Involvement of E-cadherin-mediated cell adhesion","volume":"281","author":"J Iijima","year":"2006","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"13811","DOI":"10.1074\/jbc.271.23.13811","article-title":"Aberrant glycosylation of E-cadherin enhances cell\u2013cell binding to suppress metastasis","volume":"271","author":"M Yoshimura","year":"1996","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10719-012-9373-6","article-title":"The bisecting GlcNAc in cell growth control and tumor progression","volume":"29","author":"HE Miwa","year":"2012","journal-title":"Glycoconj J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/0008-5472.CAN-09-2719","article-title":"The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression","volume":"15","author":"Y Song","year":"2010","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/hmg\/ddr469","article-title":"E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2","volume":"21","author":"AC Ferreira","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"K Livak","year":"2001","journal-title":"Methods"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1083\/jcb.200601018","article-title":"The epithelial-mesenchymal transition: new insights in signaling, development, and disease","volume":"172","author":"JM Lee","year":"2006","journal-title":"J Cell Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10585-010-9367-3","article-title":"A systems view of epithelial-mesenchymal transition signaling states","volume":"28","author":"S Thomson","year":"2011","journal-title":"Clin Exp Metastasis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"32122","DOI":"10.1074\/jbc.M607274200","article-title":"N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration","volume":"281","author":"Y Zhao","year":"2006","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10231","DOI":"10.1073\/pnas.172380699","article-title":"Glycosylation defining cancer malignancy: new wine in an old bottle","volume":"99","author":"S Hakomori","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/73163","article-title":"Suppression of tumor growth and metastasis in Mgat5- deficient mice","volume":"6","author":"M Granovsky","year":"2000","journal-title":"Nat Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.yexcr.2010.02.008","article-title":"Hypoglycosylated E-cadherin promotes the assembly of tightjunctions through the recruitment of PP2A to adherens junctions","volume":"316","author":"M Nita-Lazar","year":"2010","journal-title":"Exp Cell Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/1535-7163.MCT-11-0327","article-title":"Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R\/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines","volume":"11","author":"H Zhao","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.onc.1204064","article-title":"Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation","volume":"20","author":"C Desbois-Mouthon","year":"2001","journal-title":"Oncogene"},{"key":"ref34","first-page":"1153","article-title":"Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor. Future","volume":"1","author":"MJ Mulvihill","year":"2009","journal-title":"Journal of Med Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15419060701463116","article-title":"Autocrine production of insulin-like growth factor-I (IGF-I) affects paracellular transport across epithelial cells in vitro","volume":"14","author":"JM Paye","year":"2007","journal-title":"Cell Commun Adhes"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e33191","DOI":"10.1371\/journal.pone.0033191","article-title":"Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions","volume":"7","author":"SS Pinho","year":"2012","journal-title":"PLOS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0081579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T10:29:43Z","timestamp":1716200983000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0081579"}},"subtitle":[],"editor":[{"given":"Chih-Hsin","family":"Tang","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,11,25]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0081579","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,25]]}}}